NCT06844708

CMTS0929 for Inflammatory Bowel Disease

CMTS0929 for Inflammatory Bowel Disease: a Prospective, Open-label, Single-arm Clinical Study

• Status: Not Yet Recruiting
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 12 (estimated)
• Sponsor: The Second Hospital of Nanjing Medical University · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This is a prospective, open-label, single-arm study to explore the safety and the efficacy of China Microbiota Transplantation System 0929 (CMTS0929) for patients with inflammatory bowel disease (IBD).

Detailed description

At least 12 subjects who meet all the inclusion criteria but do not meet any exclusion criteria will be enrolled in this study. Data of demographic characteristics and clinical data will be collected. After treatment, they will enter the follow-up period for safety and efficacy evaluation.

Conditions

• Inflammatory Bowel Disease (IBD)

Interventions

Type	Name	Description
BIOLOGICAL	CMTS0929	China Microbiota Transplantation System 0929 (CMTS0929) is defined as suspension from washed microbiota.

Timeline

• Start date: 2025-02-20
• Primary completion: 2030-01-31
• Completion: 2030-07-01
• First posted: 2025-02-25
• Last updated: 2025-02-25

Locations

1 site across 1 country: China